For anyone interested in investing in the health-care space, JPMorgan's annual Health Care Conference has become one of the most important events of the year. We were not able to get to San Francisco this year, but one of our favorite Odd Lots guests, James van Geelen of CitriniResearch.com, was in attendance. He called into this week's episode of Lots More to tell us what the leading players in health care and medical technology are buzzing about right now — and he confirms that AI and GLP-1 weight loss drugs are at the top of everyone's mind."
See omnystudio.com/listener for privacy information.
The Fed's Michael Barr on Real-Time Payments and the Basel Endgame
Lina Khan Is Sending a Message to the Private Equity Industry
What's Been Happening With the Iranian Stock Market
The OCC’s Michael Hsu on the Big Risks Facing Banking Businesses Right Now
Introducing: Elon, Inc.
The Economics of Building a Childcare Business
Dimensional Co-CEO Gerard O'Reilly on the Future of Fund Management
What the Summer of Strikes Means For The Broader Economy
The Incredible Rise of the Celsius Energy Drink
What's Really Standing in the Way of a Nuclear Renaissance?
Lots More with Gregory Brew
This Is What an 8% Mortgage Means For the Housing Market
How An Old Banking Regulation May Have Driven The 1970s Inflation
NY's Cannabis Rollout Could Destroy a Legal Entrepreneur
JPMorgan's Jay Barry on the Big Selloff in Bonds
Jigar Shah on the Pathway to Clean, Cheap, and Abundant Energy
Austan Goolsbee on the 'Golden Path' to a Soft Landing
The Fed's Tom Barkin On the Impact of Higher Interest Rates
Lots More with Matt Levine and Mike Mackenzie
The Real Pain From Rate Hikes May Still Be on the Way
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
The Daily
TED Radio Hour
FT Alphachat
Freakonomics Radio
Goldman Sachs Exchanges